Cargando…
STEMI Secondary to Coronary Vasospasm: Possible Adverse Event of Methylphenidate in a 21-Year-Old Man with ADHD
Methylphenidate (Ritalin(®)) is an increasingly used medication in the treatment of attention-deficit hyperactivity disorder (ADHD). Cardiovascular adverse effects like vasospasm or myocardial infarction are described as very rare adverse effects. We present the case of a 21-year-old man diagnosed w...
Autores principales: | Baumeister, Timo-Benjamin, Wickenbrock, Ingo, Perings, Christian A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033796/ https://www.ncbi.nlm.nih.gov/pubmed/27747690 http://dx.doi.org/10.1007/s40800-016-0035-7 |
Ejemplares similares
-
ADHD, Methylphenidate, and Childhood Epilepsy
por: Sharma, Rahul, et al.
Publicado: (2016) -
Methylphenidate-Induced Psychotic Symptoms in 65-Year-Old Female with ADHD
por: Ghadrdan, Elliyeh, et al.
Publicado: (2018) -
The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD
por: Bieś, Rafał, et al.
Publicado: (2023) -
Comorbidities in ADHD children treated with methylphenidate: a database study
por: Kraut, Angela A, et al.
Publicado: (2013) -
Effect of Methylphenidate on Sleep Parameters in Children with ADHD
por: Lee, Sang Heon, et al.
Publicado: (2012)